- Home
- CDXS vs MBCN Comparison
CDXS vs MBCN Comparison
Compare CDXS & MBCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- MBCN
- Stock Information
- Founded
- CDXS 2002
- MBCN 1901
- Country
- CDXS United States
- MBCN United States
- Employees
- CDXS N/A
- MBCN N/A
- Industry
- CDXS Major Chemicals
- MBCN Major Banks
- Sector
- CDXS Industrials
- MBCN Finance
- Exchange
- CDXS Nasdaq
- MBCN Nasdaq
- Market Cap
- CDXS 201.3M
- MBCN 234.0M
- IPO Year
- CDXS 2010
- MBCN N/A
- Fundamental
- Price
- CDXS $2.30
- MBCN $29.35
- Analyst Decision
- CDXS Buy
- MBCN Hold
- Analyst Count
- CDXS 2
- MBCN 1
- Target Price
- CDXS $11.00
- MBCN $32.00
- AVG Volume (30 Days)
- CDXS 1.0M
- MBCN 8.6K
- Earning Date
- CDXS 05-14-2025
- MBCN 07-17-2025
- Dividend Yield
- CDXS N/A
- MBCN 2.86%
- EPS Growth
- CDXS N/A
- MBCN N/A
- EPS
- CDXS N/A
- MBCN 2.00
- Revenue
- CDXS $49,815,000.00
- MBCN $66,931,000.00
- Revenue This Year
- CDXS $2.41
- MBCN $15.08
- Revenue Next Year
- CDXS $34.28
- MBCN $5.02
- P/E Ratio
- CDXS N/A
- MBCN $14.64
- Revenue Growth
- CDXS N/A
- MBCN N/A
- 52 Week Low
- CDXS $1.90
- MBCN $20.61
- 52 Week High
- CDXS $6.08
- MBCN $34.00
- Technical
- Relative Strength Index (RSI)
- CDXS 44.61
- MBCN 57.30
- Support Level
- CDXS $2.30
- MBCN $28.66
- Resistance Level
- CDXS $2.56
- MBCN $29.70
- Average True Range (ATR)
- CDXS 0.20
- MBCN 0.63
- MACD
- CDXS -0.01
- MBCN -0.10
- Stochastic Oscillator
- CDXS 46.67
- MBCN 67.65
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About MBCN Middlefield Banc Corp.
Middlefield Banc Corp is a bank holding company. It offers customers, banking services including checking, savings, negotiable order of withdrawal (NOW) accounts, money market accounts, time deposits, commercial loans, real estate loans, a variety of consumer loans, safe deposit facilities, and travelers' checks. It also provides online banking and bill payment services to individuals and online cash management services to business customers.